文献速递肿瘤 PET/CT

前列腺癌患者皮肤纤维瘤显示68Ga-PSMA摄取

68Ga-PSMA Uptake by Dermatofibroma in a Patient With Prostate Cancer.
PubMed 文献 · Clin Nucl Med · 2017-01-01

一名71岁前列腺癌患者在PSA升高后行68Ga-PSMA PET/CT再分期,检出局灶性PSMA摄取的皮下病变,切除后组织病理诊断为皮肤纤维瘤,提示皮肤纤维瘤可表达PSMA并在PET/CT上表现为摄取。

要点

  • 68Ga-PSMA PET/CT可用于确定前列腺癌范围。
  • 多种其他肿瘤也可能表达PSMA并在PET/CT上显示摄取。
  • 皮肤纤维瘤可表现为局灶性PSMA摄取,需组织病理确诊。

核心结论

  • 前列腺癌患者皮下病变显示局灶性68Ga-PSMA摄取,切除后组织病理诊断为皮肤纤维瘤。

研究设计与样本

  • 病例报告:一名71岁前列腺癌患者因前列腺特异性抗原水平升高行68Ga-PSMA PET/CT再分期。

主要发现

  • 68Ga-PSMA PET/CT检出显示局灶性PSMA摄取的皮下病变,其中一处被切除。
  • 切除病变的组织病理学诊断为皮肤纤维瘤。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Prostate-specific membrane antigen (PSMA) is a typ. 2 transmembrane protein that is highly expressed in prostate cancer cells. Ga-PSMA PET/CT imaging is a modality used to determine the extent of prostate cancer. Various other neoplasias may also express PSMA, which appears as Ga-PSMA uptake in PET/CT imaging. A 71-year-old man with prostate cancer underwent Ga-PSMA PET/CT imaging for restaging after having an elevated prostate-specific antigen level. Subcutaneous lesions showing focal PSMA uptake were detected, one of which was excised. The histopathologic diagnosis was dermatofibroma.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Aydin F, Akçal A, Ünal B, et al. 68Ga-PSMA Uptake by Dermatofibroma in a Patient With Prostate Cancer. Clin Nucl Med. 2017. PMID: 28240656. doi:10.1097/RLU.0000000000001591

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。